Eyenovia announces publication of mist pivotal studies demonstrating the efficacy and safety of its map™ fixed-combination tropicamide-phenylephrine product for mydriasis

New york--(business wire)-- #optejet--eyenovia's map™ fixed-combination pharmaceutical for pupil dilation has been shown to be safe, effective and superior in comparative study.

EYEN Ratings Summary

EYEN Quant Ranking